MedPage Today invited specialists from leading medical institutions to weigh in on the latest advancements in hepatitis C with one question each day for 10 days. In this installment, we asked: “DAAS in the pipeline: What’s coming?”
Our participants are:
Fred Poordad, MD, clinical professor of medicine, The University of Texas Health Science Center at San Antonio
Raymond T. Chung, MD, medical director of liver transplant, Massachusetts General Hospital
Source: DAAS in the Pipeline: What‘s coming?
Author Info
